<DOC>
	<DOCNO>NCT00366925</DOCNO>
	<brief_summary>The purpose study compare safety efficacy 5 Adacolumn® treatment 5 week 10 treatment ( two Adacolumn® apheresis treatment first 2 week , follow 6 week one Adacolumn® apheresis treatment ) patient active ulcerative colitis .</brief_summary>
	<brief_title>CESA 5.10 Investigation Compare Efficacy Safety Adacolumn® Apheresis Device Patients With Active Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>1 . 1875 year old 2 . Active ulcerative colitis document clinical symptom , endoscopic finding histology ( patient history ) 3 . Moderate severe active ulcerative colitis baseline evaluation , define follow : Clinical activity idex ( CAI ) score &gt; 6 ; Stool frequency score 2 3 4 . Colonic involvement ulcerative colitis beyond 15 cm anal verge 5 . Ulcerative colitis least 3 month 6 . Adequate peripheral venous access allow completion apheresis treatment , demonstrate ability successfully undergo brief venous access procedure 7 . Receiving one follow medical therapy : Sulfasalazine , mesalamine 5aminosalicylic acid ( 5ASA ) agent 4 week stable dose last 2 week A maximum 20 mg per day prednisone stable dose last 2 week , 6mercaptopurine azathioprine 12 week stable dose last 4 week ; OR Have receive medical therapy due intolerance demonstrate nonresponse time period specify : Sulfasalazine , mesalamine 5ASA agent 2 week Prednisone 2 week , 6mercaptopurine azathioprine 4 week 8 . For female subject childbearing potential , negative pregnancy test agreement use effective contraceptive method abstain sexual intercourse course clinical investigation 9 . Agree participate require followup visit 10 . Able complete diary 11 . Signed write informed consent document 1 . Febrile ( &gt; 38ºC ) 2 . Evidence toxic megacolon 3 . Anticipated need surgery within 12 week 4 . Known obstructive disease gastrointestinal system 5 . Proctocolectomy , total colectomy , ileostomy , stoma ileal pouchanal anastomosis 6 . A history allergic reaction heparin heparininduced thrombocytopenia 7 . A history hypersensitivity reaction associate apheresis procedure intolerance apheresis procedures 8 . Requires central venous access catheter apheresis treatment 9 . Known infection enteric pathogen , pathogenic ovum parasite , positive assay C. difficile toxin 10 . Hypotension ( systolic blood pressure &lt; 90 mmHg and/or diastolic blood pressure &lt; 65 mmHg ) screen visit 11 . Uncontrolled hypertension ( systolic blood pressure &gt; 180 mmHg diastolic blood pressure &gt; 120 mmHg ) despite medical therapy screen visit 12 . A history myocardial infarction unstable angina within past 6 month 13 . A history coronary artery bypass graft surgery angioplasty within past 6 month 14 . A history physical finding compatible cerebrovascular accident 15 . Congestive heart failure ( New York Heart Association Class III IV ) 16 . Prosthetic heart valve , pacemaker permanent implant 17 . Severe cardiovascular peripheral vascular disease 18 . Liver disease define level SGOT [ AST ] , SGPT [ ALT ] alkaline phosphatase &gt; 2.5x upper limit normal range laboratory perform test 19 . History cirrhosis 20 . Renal insufficiency , define serum creatinine &gt; 150 % upper limit normal range laboratory perform test 21 . Insulindependent type I type II diabetes . ( Patients receive oral antidiabetic treatment include . ) 22 . Known bleed disorder ( PT PTT &gt; 1.5x upper limit normal range laboratory perform test ) , concomitant anticoagulant therapy purpose apheresis treatment 23 . Prior history suggestive hypercoagulable disorder , include 1 episode pulmonary embolism deep vein thrombosis 24 . Known infection hepatitis B C , HIV 25 . Abnormal hematology parameter define severe anemia hemoglobin &lt; 8.5 g/dL , white blood cell count &lt; 3,500/ul granulocyte count &lt; 2,000/μl 26 . Fibrinogen level &gt; 700 mg/dL 27 . Major surgery within past 6 week 28 . Infection : Active infection less 4 week successful completion antibiotic treatment routine bacterial infection Febrile viral infection within 4 week entry clinical investigation Less 12 week conclusion therapy systemic fungal infection 29 . Malignancy within past 2 year surgically cure skin carcinoma cervical dysplasia ( CIN III ) 30 . History dysplasia carcinoma colon 31 . Current drug alcohol abuse 32 . Pregnant , lactate plan become pregnant course clinical investigation 33 . Used within last 30 day , investigational drug , biologic device 5 half life , know , investigational drug biologic 34 . Received cyclosporine tacrolimus within last 4 week 35 . Received infliximab within last 8 week 36 . Received oral budesonide within last 2 week 37 . Used topical therapy ulcerative colitis within last 2 week 38 . Previously receive Adacolumn® treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>